- Home >
- Life Sciences >
- Pharmaceutical >
- Therapy >
Therapy Industry Analysis and Statistics (since 2008 - p5)
All premium reports for Therapy Industry Analysis and Statistics (since 2008 - p5)
121-150 of 157 Premium Reports from 18 Publishers
Central Nervous System Obsessive-Compulsive Disorder
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Obsessive-Compulsive Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of obsessive-compulsive disorder drugs by company and by stage as well as a summary of the latest news and d ...
Industries : Therapy
Central Nervous System Panic Disorder
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Panic Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of panic disorder drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope ...
Industries : Therapy
Central Nervous System Parkinson Disease
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Parkinson Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of parkinson disease drugs by company and by stage as well as a summary of the latest news and developments in this area ...
Industries : Therapy
Central Nervous System Psychotic Disorders
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Psychotic Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of psychotic disorders drugs by company and by stage as well as a summary of the latest news and developments in this ...
Industries : Therapy
Central Nervous System Schizophrenia
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Schizophrenia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of schizophrenia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope o ...
Industries : Therapy
Central Nervous System Stroke
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Stroke contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of stroke drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:E ...
Industries : Therapy
Central Nervous System Vertigo
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Vertigo contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of vertigo drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...
Industries : Therapy
Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persistent unmet needs
- $ 3 800
- March 2009
IntroductionOnly 15-20% of pancreatic cancer patients have resectable disease, therefore most receive systemic therapy. Gemzar (gemcitabine; Eli Lilly) forms the current standard of care for advanced disease. Despite this, no treatment is truly effective, with five-year survival at 5% for all stages ...
Industries : Therapy
US Oncology, Inc. - Strategic Analysis Review
- $ 125
- March 2009
US Oncology, Inc. - Strategic Analysis ReviewSummaryUS Oncology, Inc. (US Oncology) is a leading cancer care services company in the US. The company is principally engaged in the provision of services to physicians treating cancer patients. It provides these services to around 1,067 affiliated physi ...
Industries : Manage Care, Therapy
Alternative Medicines & Therapies in UK
- $ 749
- February 2009
- 150 pages
The Plimsoll Portfolio Analysis - Alternative Medicines & Therapies is a comprehensive evaluation of the UK market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the ...
Industries : Therapy | Countries : United Kingdom
Alcohol/Substance Abuse & Dependency - Clinical Guideline, 2nd edition (2009 update)
- $ 55
- February 2009
Clinical guideline for screening, evaluation and management of alcohol and substance abuse disorders with extensive references and resources. Review criteria for out- or inpatient care - admission, continuing care and discharge are included. ...
Industries : Therapy
Managing Physical/Occupational/Speech Therapy and Rehabilitation Care
- $ 275
- February 2009
2-volume compendium of detailed review criteria guidelines for adult and pediatric (outpatient and/or inpatient) therapy visits including modalities. The estimated number of visits to treat specific conditions with instruction for self-directed care are listed, as well as guidelines for adult and pe ...
Industries : Therapy
Disease State Management Strategies. I - Clinical Guidelines for Primary Care
- $ 275
- February 2009
Diagnosis, evaluation and treatment guidelines for asthma, COPD, diabetes, hypertension, smoking cessation, cardiovascular disease/stroke prevention, hormonal therapy, heart failure and obstetrical care guidelines for perinatal LOS and the prevention of preterm deliveries plus ?Wellness?/Preventive ...
Industries : Diagnostics, Therapy
Clinical Guidelines for Asthma, Hypertension, Heart Failure, Hormone Replacement Therapy, Preventive Healthcare by age and sex; Prevention of stroke and coronary artery disease; ADHD
- $ 55
- February 2009
Each evidence-based guideline covers diagnosis and management along with resources that include authoritative references, forms, patient education, web links. All are current. ...
Industries : Therapy
Chronic obstructive pulmonary disease (COPD)
- $ 55
- February 2009
Clinical guideline for the evaluation and management of COPD and obstructive sleep apnea. Evidence-based criteria for screening, tests, and treatments including lung transplantation, smoking cessation programs, durable medical equipment and oxygen are described. Authoritative references and resource ...
Industries : Therapy
Obesity ? Behavioral, Medical and Surgical Management, 2nd edition
- $ 65
- February 2009
Obesity evaluation and multi-faceted management approaches to lead to health improvements through behavioral modification, balanced low-fat nutritional intake, daily exercise and, in severe obesity, surgical therapy considerations. Extensive medical literature references, resource information - BMI ...
Industries : Therapy
Neurodegenerative Market Forecast to 2013
- $ 9 995
- January 2009
Executive SummaryWhich Alzheimer?s blockbuster faces diminishing sales within the next decade? What has the potential to take its place? Which class of MS drugs is emerging as successful? What innovative treatments are on the horizon? Who is on track to become a market leader? Neurodegenerative Mark ...
Industries : Therapy
Cancer Bundle
- $ 17 340
- December 2008
The Cancer Bundle includes the following reports off the individual reports being purchased separately: ? Biomarker Technology Platforms for Cancer Diagnoses and Therapies.? Cancer Cell Therapy Markets.? Cancer Diagnostic Testing World Markets.? Cancer Therapeutics Markets.? Companion Diagnostics i ...
Industries : Therapy
Global Radiation Therapy Market: 2008 Edition
- $ 900
- November 2008
- 31 pages
The radiation therapy market is growing rapidly with annual cancer rates worldwide projected to increase by fifty percent by 2020. This sharp increase in cancer cases is mainly attributed to aging population, increasing number of smokers and unhealthy life styles. The major growth drivers of radiati ...
Industries : Medical Devices, Therapy
Disease and Therapy Review: Neuropathic Pain
- $ 900
- November 2008
The Neuropathic Pain Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries, as available worldwide. Information specific to diabetic neuropathies and postherpetic neuralgia are covered in-depth. Other types of neuropathic pain, such as neuropathic ...
Disease and Therapy Review: Senile Dementia
- $ 900
- October 2008
The Senile Dementia Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and dementia types, and an overview of treatments. Dosing information and treatment costs are provided for Aricept, Namenda, Razadyne, an ...
Disease and Therapy Review: Attention Deficit Hyperactivity Disorder
- $ 900
- October 2008
The ADHD Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide. Diagnosis, treatment, associated cost, and market size information are also provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a ...
Disease and Therapy Review: Schizophrenia
- $ 900
- October 2008
The Schizophrenia Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments. Dosing information and treatment costs are provided for a wide range of products. General information is i ...
Disease and Therapy Review: Overactive Bladder
- $ 900
- October 2008
The Overactive Bladder Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide. Diagnosis, treatment, associated cost, and market size information are also provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key ...
Disease and Therapy Review: Cervical Cancer
- $ 900
- September 2008
The Cervical Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, 5-year survival rates by stage, and information on diagnosis, staging, and an overview of treatments for prevention, emergency measures and specific measures such ...
Disease and Therapy Review: Rheumatoid Arthritis
- $ 900
- July 2008
The Rheumatoid Arthritis Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments. Dosing information is provided for key products. General information is included on DMARD and TNF inhibitor sales. Disease a ...
Disease and Therapy Review: Crohn's Disease
- $ 900
- July 2008
The Crohn's Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments, including 5-ASA, corticosteroids, antibiotics, immune modifiers, biologic therapies, surgery, and other options. Dosing information is prov ...
Disease and Therapy Review: Irritable Bowel Syndrome
- $ 900
- July 2008
The Irritable Bowel Syndrome Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide. Information on diagnosis, laboratory findings and special examinations and differential diagnosis are also provided. Treatments options such as dietary therapy, pharm ...
US Oncology: Company Profile
- $ 350
- June 2008
- 25 pages
This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the oppo ...
US Oncology: Competitive Intelligence
- $ 800
- June 2008
- 35 pages
This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and ...
reportlinker.com © Copyright 2009. All rights reserved